STOCK TITAN

First Trust entities disclose 10.1M-share NeoGenomics (NEO) position in 13G

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

NeoGenomics, Inc. is reported to have 10,113,261 shares of its common stock beneficially owned by First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation, representing 7.77% of the class. First Trust Advisors L.P. and The Charger Corporation report shared voting and shared dispositive power over these shares, while First Trust Portfolios L.P. reports no voting or dispositive power.

The position is largely held through unit investment trusts sponsored by First Trust Portfolios L.P. and other investment vehicles advised by First Trust Advisors L.P. All three reporting entities jointly file under Rule 13d-1(k)(1) and expressly disclaim beneficial ownership of the reported shares.

Positive

  • None.

Negative

  • None.
Beneficial ownership 7.77% Percentage of NeoGenomics common stock reported as beneficially owned
Shares beneficially owned 10,113,261 shares Total NeoGenomics common shares reported by the First Trust filing group
Shared voting power 10,113,261 shares Shares over which First Trust Advisors L.P. and The Charger Corporation report shared voting power
Shared dispositive power 10,113,261 shares Shares over which First Trust Advisors L.P. and The Charger Corporation report shared dispositive power
Sole voting power 0 shares Sole voting power reported by each First Trust reporting person
Filing date 07/30/2026 Date signed by James M. Dykas on behalf of the reporting entities
beneficial ownership financial
"Each of First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation disclaims beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
unit investment trusts financial
"First Trust Portfolios L.P. acts as sponsor of certain unit investment trusts which hold shares"
A unit investment trust (UIT) is a pooled investment that sells investors fixed “units” representing a pre-selected, unchanging bundle of stocks, bonds or other securities held for a set period. Think of it like buying a pre-packed grocery basket that won’t be rearranged — you know exactly what you own and roughly when it will end. UITs matter to investors because they offer predictable holdings and income patterns, lower active management, and clear tax and fee implications compared with regularly traded funds.
dispositive power financial
"Sole Dispositive Power 0.00 8 | Shared Dispositive Power 10,113,261.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Rule 13d-1(k)(1) regulatory
"jointly filed by The Charger Corporation, First Trust Portfolios L.P. and First Trust Advisors L.P. pursuant to Rule 13d-1(k)(1)"
Rule 12d1-4 regulatory
"Subject to the requirements of Rule 12d1-4 under the Investment Company Act of 1940"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of NeoGenomics (NEO) shares does First Trust report owning?

First Trust entities report beneficial ownership of 7.77% of NeoGenomics common stock. This corresponds to 10,113,261 shares, held primarily through unit investment trusts and other investment vehicles they sponsor or advise.

How many NeoGenomics (NEO) shares are reported as beneficially owned by First Trust?

First Trust entities collectively report 10,113,261 shares of NeoGenomics common stock as beneficially owned. This stake represents 7.77% of the outstanding class according to the Schedule 13G filing.

Who are the reporting persons in the NeoGenomics (NEO) Schedule 13G?

The reporting persons are First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation. The Charger Corporation is the general partner of both partnerships, and the three entities filed jointly under Rule 13d-1(k)(1).

Do First Trust entities have voting power over their NeoGenomics (NEO) shares?

First Trust Advisors L.P. and The Charger Corporation report shared voting power over 10,113,261 shares. First Trust Portfolios L.P. reports no voting power, with many shares voted instead by trustees of the unit investment trusts that hold them.

How are NeoGenomics (NEO) shares held by First Trust investment products?

Many shares are held in unit investment trusts sponsored by First Trust Portfolios L.P.. Additional shares are held in registered investment companies, pooled vehicles, and separately managed accounts for which First Trust Advisors L.P. serves as investment advisor or sub-advisor.

Do the First Trust entities claim full beneficial ownership of NeoGenomics (NEO) shares?

No. Each of First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation disclaims beneficial ownership of the NeoGenomics shares identified, despite reporting them for Schedule 13G purposes as beneficially owned.





64049M209

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



First Trust Portfolios L.P.
Signature:/s/ James M. Dykas
Name/Title:James M. Dykas, Chief Financial Officer
Date:07/30/2026
First Trust Advisors L.P.
Signature:/s/ James M. Dykas
Name/Title:James M. Dykas, Chief Financial Officer
Date:07/30/2026
The Charger Corporation
Signature:/s/ James M. Dykas
Name/Title:James M. Dykas, Chief Financial Officer and Treasurer
Date:07/30/2026
Exhibit Information

Please see Exhibit 99.1 for Joint Filing Agreement